Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$54.33 - $89.52 $10 Million - $16.5 Million
-184,512 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$49.34 - $68.76 $9.1 Million - $12.7 Million
184,512 New
184,512 $185,000
Q1 2019

May 06, 2019

SELL
$48.23 - $66.16 $164,705 - $225,936
-3,415 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$52.05 - $66.51 $177,750 - $227,131
3,415 New
3,415 $225,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Family Firm, Inc. Portfolio

Follow Family Firm, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.